IperionX (NASDAQ:IPX) Chairman Todd Hannigan Acquires 260,000 Shares

IperionX Limited Sponsored ADR (NASDAQ:IPX) Chairman Todd Hannigan bought 260,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 29th. The shares were acquired at an average price of $4.20 per share, with a total value of $1,092,000.00. Following the purchase, the chairman owned 26,108,334 shares in the company, valued at $109,655,002.80. This trade represents a 1.01% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

IperionX Price Performance

Shares of NASDAQ IPX opened at $29.05 on Thursday. IperionX Limited Sponsored ADR has a 12 month low of $19.43 and a 12 month high of $61.45. The business’s 50 day moving average is $34.48 and its two-hundred day moving average is $39.12. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03.

IperionX (NASDAQ:IPX) last posted its quarterly earnings data on Saturday, January 31st. The company reported ($0.50) earnings per share for the quarter. On average, analysts predict that IperionX Limited Sponsored ADR will post -0.12 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have issued reports on IPX shares. BTIG Research began coverage on shares of IperionX in a research report on Friday, March 27th. They issued a “buy” rating and a $40.00 price target on the stock. B. Riley Financial reduced their target price on shares of IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a research note on Friday, March 13th. Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a research report on Tuesday, April 21st. William Blair started coverage on IperionX in a research note on Tuesday, January 13th. They set an “outperform” rating on the stock. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $74.00 price target on shares of IperionX in a report on Tuesday, January 20th. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $55.33.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp bought a new position in IperionX during the third quarter worth about $36,000. JPMorgan Chase & Co. bought a new stake in shares of IperionX in the 2nd quarter valued at approximately $66,000. State of Tennessee Department of Treasury acquired a new position in shares of IperionX in the 4th quarter worth approximately $119,000. DV Equities LLC bought a new position in shares of IperionX during the 4th quarter worth approximately $178,000. Finally, Vanguard Personalized Indexing Management LLC bought a new position in shares of IperionX during the 3rd quarter worth approximately $297,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

About IperionX

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.